Bosworth Andrew 4
4 · Meta Platforms, Inc. · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
Meta (META) CTO Andrew Bosworth Receives Large Equity Award
What Happened
- Andrew (Andy) Bosworth, Chief Technology Officer of Meta Platforms, received multiple equity awards on 2026-03-20 totaling 733,189 units (grants reported at $0.00 per unit). The filing lists these as derivative awards (RSUs and/or stock options) that represent contingent rights to equity rather than open-market purchases or sales.
- The grants were reported as eight tranches: 79,324; 12,806; 18,066; 29,340; 97,541; 155,491; 249,382; and 91,239 units (total 733,189). No cash was paid at grant; value will depend on future settlement/stock price and vesting conditions.
Key Details
- Transaction date: March 20, 2026. Form 4 filed March 24, 2026 (four days after the transaction).
- Reported price: $0.00 (award/grant). Transaction code: A (award/acquisition of derivative).
- Shares/units granted (by tranche): 79,324; 12,806; 18,066; 29,340; 97,541; 155,491; 249,382; 91,239 (total 733,189).
- Shares owned after transaction: not specified in the provided excerpt of the filing.
- Footnotes of note:
- F1: Each RSU equals a contingent right to receive 1 share of Class A common stock on settlement.
- F2: RSUs (where applicable) vest quarterly as to 1/16th beginning May 15, 2026, subject to continued service.
- F3–F4: Options (where applicable) include a price‑vesting period through Feb 14, 2028 (vesting if stock meets/exceeds tranche exercise price during that period); remaining unvested tranches follow a time‑based vesting schedule from Feb 15, 2028 through Aug 15, 2030.
- Late filing note: The Form 4 was filed 4 days after the reported transaction date; Form 4s are normally due within two business days—investors can check the SEC record for any late‑filing designation.
Context
- RSUs: These are contingent rights to shares that settle if/when vesting conditions are met; they do not represent immediate cash or sales.
- Stock options: Some tranches vest only if Meta’s stock reaches or exceeds specified exercise prices during a defined price‑vesting window; otherwise remaining options vest on a time schedule.
- Interpretation: Awards are routine compensation tools for executives. They are not the same as purchases (which some investors view as a bullish signal) nor sales (which can be liquidity events).
Insider Transaction Report
Form 4
Bosworth Andrew
Chief Technology Officer
Transactions
- Award
Restricted Stock Units (RSU) (Class A)
[F1][F2]2026-03-20+79,324→ 79,324 total→ Class A Common Stock (79,324 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+12,806→ 12,806 totalExercise: $1116.08Exp: 2031-03-19→ Class A Common Stock (12,806 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+18,066→ 18,066 totalExercise: $1393.87Exp: 2031-03-19→ Class A Common Stock (18,066 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+29,340→ 29,340 totalExercise: $1724.41Exp: 2031-03-19→ Class A Common Stock (29,340 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+97,541→ 97,541 totalExercise: $2114.87Exp: 2031-03-19→ Class A Common Stock (97,541 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+155,491→ 155,491 totalExercise: $2573.06Exp: 2031-03-19→ Class A Common Stock (155,491 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+249,382→ 249,382 totalExercise: $3107.44Exp: 2031-03-19→ Class A Common Stock (249,382 underlying) - Award
Stock Options (right to buy)
[F3][F4]2026-03-20+91,239→ 91,239 totalExercise: $3727.12Exp: 2031-03-19→ Class A Common Stock (91,239 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement.
- [F2]The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date.
- [F3]The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.
- [F4]Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.
Signature
/s/ Erin Guldiken, attorney-in-fact for Andrew Bosworth|2026-03-24